Sabinsa Corporation was recently assigned a patent (U.S. Patent #5,783,603, dated July 21, 1998) for Citrin®K. The patent titled "Potassium hydroxycitrate for the suppression of appetite and induction of weight loss", provides methods of suppressing appetite, inhibiting cytoplasmic citrate lyase and increasing fat metabolism in obese subjects, using the potassium salt of hydroxycitric acid from Garcinia fruit. Citrin®K is a water soluble product, available in two forms: a standardized powdered extract and a standardized liquid.
Sabinsa Corporation Assigned Patent for Citrin®K
- Hits: 88